Important Argentine advance to treat HIV | Society

The AIDS 2018 conference was held in Amsterdam. Photo: Fundación Huésped

The Scientific Director of Fundación Huésped, Pedro Cahn, presented the results of the GEMINI study, which demonstrate that a treatment with two drugs has an efficacy similar to that of three drugs in patients infected with HIV. "In the last 15 or 20 years, the standard of HIV treatment revolved around a three-drug regimen, and now that we have more powerful drugs, the focus is on tolerance and the convenience, "he explains. The specialist

The data was presented as part of the 22nd International AIDS Conference (AIDS 2018), which ended Friday in the Netherlands, according to the news agency Noticias Argentinas.

The two drugs used in the new standard are Dolutegravir and Lamivudine. The GEMINI study involved more than 1,400 people from Europe, America, Africa and Asia living with HIV and having never been treated before. . It was conducted on the basis of a fully Argentine pilot project (the PADDLE study) designed, organized and led by the Huésped Foundation.

On this basis, a laboratory designed the international GEMINI study that tested the results on a large scale. of the Argentine study.